Short-Term Outcomes of the Calcineurin Inhibitor Avoidance Maintenance Regimen with Everolimus in Kidney Transplant Recipients.

被引：0
|
作者：
Kutsunai, K. [1 ]
Iwadoh, K. [1 ]
Horibe, T. [1 ]
Ogawa, Y. [1 ]
Kai, K. [1 ]
Murakami, T. [1 ]
Koyama, I. [1 ]
Nakajima, I. [1 ]
Fuchinoue, S. [1 ]
机构：
[1] Tokyo Womens Med Univ, Dept Surg, Kidney Ctr, Tokyo, Japan
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2013年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：316 / 316
页数：1
相关论文
共 50 条
  • [21] Long-Term Results in Recipients of Late Conversion to a Calcineurin Inhibitor-Free Regimen with Everolimus After Kidney Transplantation
    Iwahara, Naoya
    Hotta, Kiyohiko
    Hirose, Takayuki
    Shinohara, Nobuo
    TRANSPLANTATION PROCEEDINGS, 2023, 55 (04) : 803 - 808
  • [22] THE TRANSFORM STUDY: INFECTION OUTCOMES WITH EVEROLIMUS PLUS REDUCED CALCINEURIN INHIBITOR AND MYCOPHENOLATE PLUS STANDARD CALCINEURIN INHIBITOR REGIMENS IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS
    Pernin, V.
    Buchler, M.
    Cruzado, J.
    Garcia, V.
    Kuypers, D.
    Citterio, F.
    Huynh-Do, U.
    Luo, W. L.
    Bernhardt, P.
    Sommerer, C.
    Gharbi, H.
    Vincenti, F.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 23 - 23
  • [23] Clinical Outcomes of Conversion from Calcineurin Inhibitor to Belatacept-Based Immunosuppression in Highly Sensitized Kidney Transplant Recipients.
    Sethi, S.
    Choi, J.
    Vo, A.
    Peng, A.
    Lim, K.
    Najjar, R.
    Jordan, S.
    Huang, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 291 - 292
  • [24] Calcineurin inhibitor-free imunosuppressive protocol with basiliximab induction and everolimus in de novo liver transplant recipients.
    Masetti, Michele
    Montalti, Roberto
    Rompianesi, Gianluca
    Di Benedetto, Fabrizio
    De Ruvo, Nicola
    Romano, Antonio
    Guerrini, Gian Piero
    Gerunda, Giorgio E.
    LIVER TRANSPLANTATION, 2007, 13 (06) : S72 - S72
  • [25] Everolimus therapeutic drug monitoring in black kidney transplant recipients.
    Rajagopalan, PR
    Mayer, H
    Hmissi, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 368A - 368A
  • [26] Genomic-Derived Markers to Identify Calcineurin Inhibitor Nephrotoxicity in Pediatric Kidney Transplant Recipients.
    Rhone, E.
    Gehrau, R.
    Bontha, S.
    Walker, P.
    Dumur, C.
    Maluf, D.
    Mas, V.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 742 - 742
  • [27] Frailty and Short-Term Outcomes in Kidney Transplant
    Van Arsdale, S.
    Torbert, K.
    Harland, R.
    Turner, A.
    Tanriover, B.
    Ariyamuthu, V.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 514 - 514
  • [28] Renal Function of an Everolimus Based Therapy after Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients
    Budde, K.
    Zeier, M.
    Haller, H.
    Arns, W.
    Kramer, S.
    Vogel, E. M.
    Pietruck, F.
    Reinke, P.
    Rath, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 504 - 504
  • [29] Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients
    Manzia, T. M.
    Angelico, R.
    Toti, L.
    Grimaldi, C.
    Sforza, D.
    Vella, I.
    Tariciotti, L.
    Lenci, I.
    Breshanaj, G.
    Baiocchi, L.
    Tisone, G.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (01) : 175 - 183
  • [30] BK nephropathy in kidney transplant recipients treated with a calcineurin inhibitor-free immunosuppression regimen
    Lipshutz, GS
    Flechner, SM
    Govani, MV
    Vincenti, F
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (12) : 2132 - 2134
12345